PPD Rated No. 1 CRO in 2011 CenterWatch Global Site Survey

Company earns top marks in 25 of 29 survey attributes

05 May 2011


WILMINGTON, N.C., (May 5, 2011) - PPD, Inc. (Nasdaq: PPDI) today announced it has earned the number one spot among contract research organizations (CROs) in the 2011 CenterWatch global site survey, with 84.3 percent of participants rating PPD's overall relationship quality as "excellent" or "good."

PPD scored among the top three in 25 of the 29 survey attributes and received the highest marks of any CRO in several categories, including staff professionalism, good protocol design, study initiation, being organized and prepared, and setting realistic project timelines. According to The CenterWatch Monthly, PPD earned the number one spot by focusing on the needs of sites, which include supplying technology and support, providing clear protocols and timelines, and concentrating on strong training programs for clinical research associates.

"We are committed to building and maintaining strong relationships with our global sites through close collaboration between our project teams and investigators," said Sebastian Pacios, M.D., senior vice president of global project management. "By providing extensive training programs for our employees, innovative technologies to aid our sites and clients, and expertise across all aspects of protocol design, we are able to partner with our sites to ensure reliable study data for our clients."

The 2011 survey marked the first time CenterWatch has conducted a global site survey, and included investigator sites in the United States and Europe. More than 1,200 clinical research professionals completed the survey, which was conducted this past February and March. The survey polled principal investigators, subinvestigators and study coordinators about the quality of their relationships with CROs.

This year's rating follows PPD's number two ranking among CROs in the 2010 CenterWatch European Site Survey. In that survey, PPD scored among the top three CROs in 26 of the 29 survey attributes and earned the highest marks for being organized and prepared and for its work style and supportive culture.

CenterWatch is a leading publishing and information services company focused on the clinical trials industry.

Except for historical information, all of the statements, expectations and assumptions, including expectations and assumptions about PPD's rating in the 2011 CenterWatch Global Site Survey, contained in this news release are forward-looking statements that involve a number of risks and uncertainties. Although PPD attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based and could cause actual results to differ materially from the forward-looking statements. Other important factors which could cause future results to differ materially include the following: competition in the outsourcing industry; rapid technological advances that make our services less competitive; risks associated with and dependence on strategic relationships; economic conditions and outsourcing trends in the pharmaceutical, biotechnology and government-sponsored research sectors; the ability to attract, integrate and retain key personnel, including a new CEO; and risks associated with acquisitions and investments. These and other PPD risk factors are set forth in more detail from time to time in our SEC filings, copies of which are available free of charge upon request from PPD's investor relations department. PPD assumes no obligation and expressly disclaims any duty to update these forward-looking statements in the future, except as required by applicable securities laws. These forward-looking statements should not be relied upon as representing PPD's estimates or views as of any date subsequent to the date hereof.

Contact Us

Media Contacts:

Randy Buckwalter Senior Manager, Corporate Communications
Tel: +1 919 456 4425

Holly Devine Manager, Corporate Communications
Tel: +1 919 456 6389

Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2019 Pharmaceutical Product Development, LLC. All rights reserved.